| 名稱 | CD80/PDL1/TCR Activator/CHO |
| 型號(hào) | CBP74129 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CD80/PDL1/TCR Activator/CHO |
產(chǎn)品搜索
相關(guān)文章
- 國(guó)內(nèi)研究者Cell Research：韓春雨NgAgo有效
- 研究發(fā)現(xiàn)氣候可能決定人的鼻子形狀
- 腫瘤細(xì)胞到底是如何“轉(zhuǎn)移”的呢？
- 第四代ALK激酶抑制劑篩選模型
- 羅氏乳腺癌新藥獲英國(guó)NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- 5月是黑色素瘤意識(shí)月，盤點(diǎn)黑色素瘤研究進(jìn)展
- NIPT標(biāo)準(zhǔn)品-助力無創(chuàng)產(chǎn)前檢測(cè)
- 人結(jié)腸癌細(xì)胞株的細(xì)胞形態(tài)是不太規(guī)則的三角形
- 喝熱茶或使食管癌風(fēng)險(xiǎn)增加5倍
- BTLA細(xì)胞篩選模型簡(jiǎn)介
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74129CD80/PDL1/TCR Activator/CHO
- 詳細(xì)內(nèi)容
| CBP74129 CD80/PDL1/TCR Activator/CHO | |
| I. Background | |
Human secreted B7-1-Fc fusion protein, also known as CD80, with C-terminal Avi-tag. GenBank Accession No. NM_005191, a.a 35-242 expressed in a HEK293 cell expression system and enzymatically biotin-labeled using Avi-tagtechnology. | |
| III. Introduction | |
| Expressed gene: | CD80 |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS+600ug/ml hygromycin+2ug/ml puromycin+5ug/ml blasticidin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| II. Representative Data | |
Figure 1. Recombinant CHO cells constitutively expressing PDL1.
Figure 2. Recombinant CHO cells constitutively expressing CD80. | |
會(huì)員_a.png)